Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Prognostic value of tumor growth kinetic parameters in prostate cancer patients.

Zharinov GM, Bogomolov OA, Neklasova NY, Raskin GA, Chepurnaya IV, Bugrov SN, Anisimov VN.

Oncotarget. 2019 Aug 20;10(49):5020-5027. doi: 10.18632/oncotarget.27088. eCollection 2019 Aug 20.

2.

RUSSCO-RSP comparative study of immunohistochemistry diagnostic assays for PD-L1 expression in urothelial bladder cancer.

Zavalishina L, Tsimafeyeu I, Povilaitite P, Raskin G, Andreeva Y, Petrov A, Kharitonova E, Rumyantsev A, Pugach I, Frank G, Tjulandin S.

Virchows Arch. 2018 Dec;473(6):719-724. doi: 10.1007/s00428-018-2453-7. Epub 2018 Sep 13.

PMID:
30209552
3.

Enhancing medical student diversity through a premedical program: A Caribbean school case study.

DeCarvalho H, Lindner I, Sengupta A, Rajput V, Raskin G.

Educ Health (Abingdon). 2018 Jan-Apr;31(1):48-51. doi: 10.4103/1357-6283.239047.

4.

Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.

Sokolenko AP, Savonevich EL, Ivantsov AO, Raskin GA, Kuligina ES, Gorodnova TV, Preobrazhenskaya EV, Kleshchov MA, Tiurin VI, Mukhina MS, Kotiv KB, Shulga AV, Kuznetsov SG, Berlev IV, Imyanitov EN.

Cancer Lett. 2017 Jul 1;397:127-132. doi: 10.1016/j.canlet.2017.03.036. Epub 2017 Apr 1.

PMID:
28377179
5.

Primary cultures of human colon cancer as a model to study cancer stem cells.

Koshkin S, Danilova A, Raskin G, Petrov N, Bajenova O, O'Brien SJ, Tomilin A, Tolkunova E.

Tumour Biol. 2016 Sep;37(9):12833-12842. Epub 2016 Jul 23.

PMID:
27449036
6.

Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan.

Silkin SV, Startsev SS, Krasnova ME, Raskin GA, Mitiushkina NV, Iyevleva AG, Sokolenko AP, Imyanitov EN.

J Gastrointest Cancer. 2016 Dec;47(4):502-505. No abstract available.

PMID:
26687137
7.

Unusual Clinical Presentation of Gastrointestinal Clear Cell Sarcoma.

Raskin GA, Pozharisski KM, Iyevleva AG, Rikov IV, Orlova RV, Imyanitov EN.

Gastrointest Tumors. 2015 Sep;2(2):83-8. doi: 10.1159/000430881. Epub 2015 May 29.

8.

[The immunohistochemical features of ovarian serous adenocarcinoma cells, which determine a disease course and survival rates in patients].

Pozharissky KM, Raskin GA, Vinokurov VL, Yurkova LE, Mukhina MS.

Arkh Patol. 2015 Jan-Feb;77(1):38-40. doi: 10.17116/patol201577138-. Russian.

PMID:
25868367
9.

Novel ALK fusion partners in lung cancer.

Iyevleva AG, Raskin GA, Tiurin VI, Sokolenko AP, Mitiushkina NV, Aleksakhina SN, Garifullina AR, Strelkova TN, Merkulov VO, Ivantsov AO, Kuligina ESh, Pozharisski KM, Togo AV, Imyanitov EN.

Cancer Lett. 2015 Jun 28;362(1):116-21. doi: 10.1016/j.canlet.2015.03.028. Epub 2015 Mar 23.

PMID:
25813404
10.

[Prognostic values of the clinical, morphological and molecular biological characteristics of colon adenocarcinoma].

Raskin GA, Pozharissky KM, Orlova RV, Petrov SV.

Arkh Patol. 2015 Sep-Oct;77(5):26-30. doi: 10.17116/patol201577526-30. Russian.

PMID:
26978017
11.

[Immunohistochemical examination of MSH2, PMS2, MLH1, MSH6 compared with the analysis of microsatellite instability in colon adenocarcinoma].

Raskin GA, Ianus GA, Kornilov AV, Orlova RV, Petrov SV, Protasova AÉ, Pozharisskiĭ KM, Imianitov EN.

Vopr Onkol. 2014;60(2):47-50. Russian.

PMID:
24919261
12.

[Proliferation of cancer stem cells in colorectal adenocarcinoma].

Raskin GA, Orlova RV, Petrov SV, Protasova AÉ, Pozharisskiĭ KM.

Vopr Onkol. 2014;60(1):47-51. Russian.

PMID:
24772616
13.

[Morphological assessment of predictive factors in adenocarcinoma of the colon].

Raskin GA, Pozharisskiĭ KM, Orlova RV.

Vopr Onkol. 2014;60(5):619-24. Russian.

PMID:
25816668
14.

[Endometrial neoplasm similar to ovarian sex cord tumor (clinical and morphologic observations)].

Raskin GA, Savost'ianov TF.

Vopr Onkol. 2013;59(2):100-2. Russian.

PMID:
23814858
15.

[Role of cancer stem cells, chemokines and their receptors in carcinogenesis, recurrences and metastatic spread of tumors].

Raskin GA, Orlova RV, Protasova AÉ, Petrov SV, Ivanova AK, Pozharisskiĭ KM.

Vopr Onkol. 2013;59(6):694-700. Russian. No abstract available.

PMID:
24624776
16.

[Use of liquid-based endometrial cytology in breast cancer patients receiving tamoxifen].

Protasova AÉ, Raskin GA, Orlova RV, Protasov DA, Tiukavina NV.

Vopr Onkol. 2011;57(5):675-9. Russian.

PMID:
22238943
17.

[Endocrine therapy for postmenopausal breast cancer (role of cycline D1)].

Manikhas AG, Skvortsov VA, Manikhas GM, Raskin GA, Oganesian AS, Shemerovskiĭ AK.

Vopr Onkol. 2011;57(5):641-4. Russian. No abstract available.

PMID:
22238936
20.

[Immunohistochemical assay of cellular cycle markers: an alternative to chip-diagnosis of breast cancer].

Petrov SV, Orlova RV, Raskin GA, Khacanov RSh.

Vopr Onkol. 2007;53(5):526-30. Russian.

PMID:
18154114
21.

[Role of palliative surgery in complex treatment for disseminated breast cancer].

Orlova RV, Moiseenko VM, Gafton GI, Kochnev VA, Shchukin VV, Semiglazov VV, Raskin GA.

Vopr Onkol. 2007;53(5):521-5. Russian.

PMID:
18154113
22.

A new hypothesis on the role of c-erbB2 oncogene in the progress of breast cancer.

Petrov SV, Raskin GA, Khasanov RSh.

Bull Exp Biol Med. 2006 Jul;142(1):94-7. English, Russian.

PMID:
17369913
23.

[Comparative immunohistochemical study of invasive duct carcinoma and Paget's disease of the breast with c-erbB-2 overexpression].

Petrov SV, Raskin GA, Khasanov RSh, Tsyplakov DE.

Arkh Patol. 2006 Sep-Oct;68(5):10-4. Russian.

PMID:
17144522
24.

The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903].

Mills E, Prousky J, Raskin G, Gagnier J, Rachlis B, Montori VM, Juurlink D.

BMC Clin Pharmacol. 2003 Nov 13;3:4.

25.

Choledochoduodenostomy.

Lachter J, Orron DE, Raskin GS.

Isr Med Assoc J. 2001 Jul;3(7):548. No abstract available. Erratum in: Isr Med Assoc J 2001 Nov;3(11):863.

26.

Reduced intracellular ionic strength as the initial trigger for activation of endothelial volume-regulated anion channels.

Voets T, Droogmans G, Raskin G, Eggermont J, Nilius B.

Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5298-303.

27.

Transepithelial capacitance decrease reveals closure of lateral interspace in A6 epithelia.

Van Driessche W, De Vos R, Jans D, Simaels J, De Smet P, Raskin G.

Pflugers Arch. 1999 Apr;437(5):680-90.

PMID:
10087144
28.

The role of childhood stressors in the intergenerational transmission of alcohol use disorders.

Sher KJ, Gershuny BS, Peterson L, Raskin G.

J Stud Alcohol. 1997 Jul;58(4):414-27.

PMID:
9203123
29.

Alcohol outcome expectancies and alcohol use: a latent variable cross-lagged panel study.

Sher KJ, Wood MD, Wood PK, Raskin G.

J Abnorm Psychol. 1996 Nov;105(4):561-574. doi: 10.1037/0021-843X.105.4.561.

PMID:
8952189
30.

Molecular and physiological aspects of nephropathy in type I (insulin-dependent) diabetes mellitus.

Raskin GS, Tamborlane WV.

J Diabetes Complications. 1996 Jan-Feb;10(1):31-7. Review. No abstract available.

PMID:
8639972
31.

An automatic monitoring system for epithelial cell height.

Van Driessche W, De Smet P, Raskin G.

Pflugers Arch. 1993 Oct;425(1-2):164-71.

PMID:
8272373
32.

Prevalence of DSM-III-R disorders among nonclinical compulsive checkers and noncheckers in a college student sample.

Sher KJ, Martin ED, Raskin G, Perrigo R.

Behav Res Ther. 1991;29(5):479-83.

PMID:
1741735
33.

Financial nurse: tax saving strategies.

Raskin G.

Nurs Careers. 1980 Nov-Dec;1(3):14. No abstract available.

PMID:
6921584

Supplemental Content

Loading ...
Support Center